Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of ALG 1001 to Treat Diabetic Macular Edema

NCT01482871 is registered in ClinicalTrials.gov with Allegro Ophthalmics, LLC as lead sponsor.

NCT NCT01482871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01482871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of ALG 1001 to Treat Diabetic Macular Edema
Lead sponsor
Allegro Ophthalmics, LLC
Phase
Phase 1/2
Overall status
Withdrawn
Start date
January 31, 2011
Completion date
November 30, 2011
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema